Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Genzyme | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Genzyme

Ron Branning has been appointed senior vice president of Global Product Quality, Genzyme.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ron Branning has been appointed senior vice president of Global Product Quality, Genzyme. In this role, he will ensure the quality of all Genzyme products manufactured at 17 sites around the world. Mr. Branning will report to Genzyme executive vice president David Meeker, M.D., and chief executive officer, Henri Termeer.

“We are committed to the highest standards of drug and device quality for patients,” said Mr. Termeer. “Ron Branning is a recognized industry leader in ensuring product quality, and we look forward to adding his experience to our corporate leadership team. Bringing in new senior leaders such as Ron is a fundamental component of our plan to renew and strengthen our manufacturing organization.”

Prior to joining the company, Mr. Branning led the quality and compliance functions at Gilead Sciences, where he was corporate vice president of Quality and Compliance, and chief compliance officer. He has also held senior quality leadership positions at Genentech, Aventis Behring, and Somatogen (Baxter).


Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters